|
Guadinomine C2 |
|
Escherichia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Iwatsuki M, et al. 2008. J Antibiot (Tokyo) |
|
Guadinomine A |
Depiction based on curated SMILES
H
2
N
N
N
O
NH
2
OH
OH
OH
NH
2
NH
2
H
3
C
H
O
N
H
H
CH
3
CH
3
O
HO
N
H
O
|
Escherichia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Iwatsuki M, et al. 2008. J Antibiot (Tokyo) |
|
Guadinomine D |
Depiction based on curated SMILES
N
N
H
2
N
O
NH
2
OH
OH
NH
2
N
H
O
H
3
C
H
3
C
H
O
N
H
H
CH
3
CH
3
O
OH
N
H
O
|
Escherichia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Iwatsuki M, et al. 2008. J Antibiot (Tokyo) |
|
Guadinomine B |
Depiction based on curated SMILES
N
N
NH
2
O
H
2
N
HO
HO
NH
2
NH
2
O
CH
3
O
HO
N
H
CH
3
H
3
C
NH
O
|
Escherichia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Iwatsuki M, et al. 2008. J Antibiot (Tokyo) |
|
8-(dimethylamino)-7-[(2,3-dimethylphenyl)methyl]-5-oxo-2,3-dihydro-[1,3]thiazolo[3,2-a]pyridine-3-carboxylic acid |
Depiction based on curated SMILES
N
CH
3
H
3
C
CH
3
N
S
O
HO
O
CH
3
|
Listeria |
PrfA (Pleiotropic regulatory factor) |
Preclinical (in vitro) |
Kulén M, et al. 2018. J Med Chem |
|
lithium;(3R)-8-cyclopropyl-5-oxo-7-(quinolin-3-ylmethyl)-2,3-dihydro-[1,3]thiazolo[3,2-a]pyridine-3-carboxylate |
Depiction based on curated SMILES
N
O
+
Li
_
O
O
S
H
N
|
Listeria |
PrfA (Pleiotropic regulatory factor) |
Preclinical (in vitro) |
Kulén M, et al. 2018. J Med Chem |
|
(2R)-2-[(5Z)-4-oxo-5-[(4-phenylmethoxycarbonylphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanoic acid |
Depiction based on curated SMILES
O
O
S
S
H
O
HO
N
O
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Mori M, et al. 2014. Bioorg Med Chem Lett |
|
(2R)-2-[(5Z)-5-[(4-methoxycarbonylphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanoic acid |
Depiction based on curated SMILES
OH
O
H
S
S
CH
3
N
O
O
O
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Mori M, et al. 2014. Bioorg Med Chem Lett |
|
4-(1-Acetyl-1H-indol-3-ylmethylene)-2-phenyl-4H-oxazol-5-one |
Depiction based on curated SMILES
N
O
O
CH
3
N
O
|
Mycobacterium |
Motility |
Preclinical (in vitro) |
Ouertatani-Sakouhi H, et al. 2017. PLoS One |
|
1'-[(3-chlorophenyl)methyl]-3-(3,4-difluorophenyl)-5'-nitro-1,1-dioxo-spiro[1,3-thiazolidine-2,3'-indoline]-2',4-dione |
Depiction based on curated SMILES
N
+
N
O
_
O
F
F
N
S
O
O
O
O
Cl
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Vintonyak VV, et al. 2010. Angew Chem Int Ed Engl |
|
| | |